The Role of Mitochondrial Dysfunction in Vascular Disease, Tumorigenesis, and Diabetes
Olga A Zhunina1, Nikita G Yabbarov1, Andrey V Grechko2
1Chemical Biology Department, Russian Research Center for Molecular Diagnostics and Therapy, Moscow, Russia.
Abstract:
Mitochondrial dysfunction is known to be associated with a wide range of human pathologies, such as cancer, metabolic, and cardiovascular diseases. One of the possible ways of mitochondrial involvement in the cellular damage is excessive production of reactive oxygen and nitrogen species (ROS and RNS) that cannot be effectively neutralized by existing antioxidant systems. In mitochondria, ROS and RNS can contribute to protein and mitochondrial DNA (mtDNA) damage causing failure of enzymatic chains and mutations that can impair mitochondrial function. These processes further lead to abnormal cell signaling, premature cell senescence, initiation of inflammation, and apoptosis. Recent studies have identified numerous mtDNA mutations associated with different human pathologies. Some of them result in imbalanced oxidative phosphorylation, while others affect mitochondrial protein synthesis. In this review, we discuss the role of mtDNA mutations in cancer, diabetes, cardiovascular diseases, and atherosclerosis. We provide a list of currently described mtDNA mutations associated with each pathology and discuss the possible future perspective of the research.
Insights
Mitochondrial DNA (mtDNA) mutations contribute to human diseases like cancer and cardiovascular conditions by causing excessive reactive oxygen species (ROS) and impairing mitochondrial function. This review details these mtDNA mutations and their pathological links.
Area of Science:
- Mitochondrial biology
- Molecular genetics
- Pathophysiology
Background:
- Mitochondrial dysfunction is implicated in numerous human diseases, including cancer, metabolic disorders, and cardiovascular conditions.
- Excessive reactive oxygen and nitrogen species (ROS/RNS) production overwhelms antioxidant systems, leading to cellular damage.
- ROS/RNS can damage mitochondrial DNA (mtDNA) and proteins, disrupting enzymatic chains and mitochondrial function.
Purpose of the Study:
- To review the role of mitochondrial DNA (mtDNA) mutations in various human pathologies.
- To compile a list of known mtDNA mutations associated with specific diseases.
- To discuss the implications and future research directions concerning mtDNA mutations in disease.
Main Methods:
- Literature review of scientific studies on mtDNA mutations and human pathologies.
- Analysis of research linking specific mtDNA mutations to cancer, diabetes, cardiovascular diseases, and atherosclerosis.
- Synthesis of current knowledge on the mechanisms of mtDNA damage and its consequences.
Main Results:
- Numerous mtDNA mutations have been identified and linked to diverse human pathologies.
- Specific mutations can lead to imbalanced oxidative phosphorylation or impaired mitochondrial protein synthesis.
- These mutations are associated with cellular dysfunction, abnormal signaling, senescence, inflammation, and apoptosis.
Conclusions:
- mtDNA mutations are significant contributors to the pathogenesis of major human diseases.
- Understanding these mutations offers insights into disease mechanisms and potential therapeutic targets.
- Further research is crucial to fully elucidate the role of mtDNA mutations and explore future perspectives.
Related Concept Videos
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway


